Compare Abbott India with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA DR. REDDYS LAB ABBOTT INDIA/
DR. REDDYS LAB
 
P/E (TTM) x 48.1 34.0 141.7% View Chart
P/BV x 15.0 4.1 367.0% View Chart
Dividend Yield % 1.5 0.6 262.0%  

Financials

 ABBOTT INDIA   DR. REDDYS LAB
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-21
DR. REDDYS LAB
Mar-21
ABBOTT INDIA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs18,5695,515 336.7%   
Low Rs13,9703,028 461.4%   
Sales per share (Unadj.) Rs2,028.21,145.4 177.1%  
Earnings per share (Unadj.) Rs325.0114.5 283.9%  
Cash flow per share (Unadj.) Rs352.4188.4 187.1%  
Dividends per share (Unadj.) Rs275.0025.00 1,100.0%  
Avg Dividend yield %1.70.6 288.8%  
Book value per share (Unadj.) Rs1,203.71,053.2 114.3%  
Shares outstanding (eoy) m21.25166.30 12.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.03.7 215.1%   
Avg P/E ratio x50.137.3 134.1%  
P/CF ratio (eoy) x46.222.7 203.6%  
Price / Book Value ratio x13.54.1 333.3%  
Dividend payout %84.621.8 387.4%   
Avg Mkt Cap Rs m345,717710,289 48.7%   
No. of employees `000NANA-   
Total wages/salary Rs m4,92736,299 13.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m43,100190,475 22.6%  
Other income Rs m8352,914 28.6%   
Total revenues Rs m43,935193,389 22.7%   
Gross profit Rs m9,18938,699 23.7%  
Depreciation Rs m58112,288 4.7%   
Interest Rs m183970 18.8%   
Profit before tax Rs m9,26028,355 32.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3539,319 25.2%   
Profit after tax Rs m6,90719,036 36.3%  
Gross profit margin %21.320.3 104.9%  
Effective tax rate %25.432.9 77.3%   
Net profit margin %16.010.0 160.3%  
BALANCE SHEET DATA
Current assets Rs m35,185145,503 24.2%   
Current liabilities Rs m10,30981,038 12.7%   
Net working cap to sales %57.733.8 170.5%  
Current ratio x3.41.8 190.1%  
Inventory Days Days461 7.3%  
Debtors Days Days295 2.2%  
Net fixed assets Rs m3,041109,979 2.8%   
Share capital Rs m213832 25.5%   
"Free" reserves Rs m25,366174,319 14.6%   
Net worth Rs m25,579175,151 14.6%   
Long term debt Rs m06,299 0.0%   
Total assets Rs m38,226255,482 15.0%  
Interest coverage x51.730.2 170.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.10.7 151.2%   
Return on assets %18.57.8 236.8%  
Return on equity %27.010.9 248.4%  
Return on capital %36.916.2 228.4%  
Exports to sales %0.751.3 1.3%   
Imports to sales %12.318.1 68.1%   
Exports (fob) Rs m29597,699 0.3%   
Imports (cif) Rs m5,30634,420 15.4%   
Fx inflow Rs m35397,699 0.4%   
Fx outflow Rs m5,38934,420 15.7%   
Net fx Rs m-5,03563,279 -8.0%   
CASH FLOW
From Operations Rs m7,26735,703 20.4%  
From Investments Rs m-718-22,660 3.2%  
From Financial Activity Rs m-5,818-298 1,952.3%  
Net Cashflow Rs m73112,858 5.7%  

Share Holding

Indian Promoters % 0.0 26.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.7 49.9 15.5%  
FIIs % 0.2 25.2 0.9%  
ADR/GDR % 0.0 11.2 -  
Free float % 25.0 62.1 40.3%  
Shareholders   90,567 263,803 34.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA    CIPLA    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    

Yellow Ad

Advertisement

A One Stock Gift in 1990 Turns into Rs 130 Crores

In 2017, Ravi made headlines by calling a leading business news channel with a surprising announcement - his grandfather had left him 20,000 shares of only one stock.

And on the day of his call - these shares were worth Rs 130 crore.

Can you guess which is this company?

It's MRF.

Ravi's story is one of the amazing stories of becoming Crorepati from a single stock.

But the question is, how to find that one stock with crorepati potential?

To find the answer to this million-dollar question, join our 'One Stock Crorepati' MEGA summit on 30th June, where we will reveal details of what we call a potential 'crorepati' stock...

Learn more



Today's Market

Sensex Zooms 462 Points, Nifty Ends Near 15,700; Auto & FMCG Stocks Rally(Closing)

Indian share markets ended the week on a firm note tracking positive global cues.

Related Views on News

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling(Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively?(Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover?(Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jun 24, 2022 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS